Air Liquide has acquired Netherlands-based Medidis, further strengthening its healthcare business in Europe.

Medidis is a nationwide player that provides home healthcare support for patients suffering from respiratory failure and sleep apnea.

The company supplies medical oxygen to patients being treated at home as well as those receiving care in assisted living facilities and to healthcare professionals who work outside the hospital setting. It also operates a medical oxygen production facility.

Present for more than 25 years in the Dutch market, this acquisition both reinforces and diversifies Air Liquide’s existing healthcare offering and allows the group to directly serve more than 26,000 additional patients in this country. Air Liquide will work with the existing teams to pursue the development of these businesses.

Already present in the Netherlands, Air Liquide said it will be able to leverage the complementarity of Medidis in both geographic and therapeutic terms.

Concerning home healthcare, this acquisition will reinforce the group’s position in the support of patients who suffer from respiratory failure. Moreover, it will increase its customer base with healthcare professionals who work outside the hospital (such as medical homes or ambulances).

Air Liquide will also benefit from Medidis’ established relationships with doctors, hospitals, and insurers in new regions and from an increased production capacity, which will allow the Group to further develop healthcare activities in the Netherlands.

François Jackow, member of the Air Liquide Executive Committee, supervising Healthcare activities stated, “This acquisition gives Air Liquide an added dimension in the Dutch market.”

“We are delighted to welcome the Medidis teams, recognised for their expertise in the treatment of respiratory diseases and their knowledge of the Dutch market, both at home and the growing market for the supply of medical oxygen outside the hospital.”

“Air Liquide thus continues its momentum in terms of strengthening its positions in Europe, which is key to our strategy of developing the Healthcare business.”